CutisPharma, Inc., based in Wilmington, Massachusetts, is a privately held, specialty pharmaceutical company that has historically developed and distributed kits used by pharmacists to safely create compounded medications for nearly 20 years. The Company’s products include oral solutions and suspensions, such as antimicrobials, mouthwashes, and PPIs; topicals, including hydrocortisone; and progesterone suppositories. The Company’s FI℞ST® Unit-of-Use Kits have benefited millions of patients who are unable to swallow conventional oral dosage forms such as tablets and capsules and whose needs were not served by commercially available therapies. Building on the strength of its legacy compounding product portfolio, the Company has recently prioritized its focus toward developing and commercializing FDA-approved drugs in niche markets of high-unmet need.
